2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$47.52+$0.66 (+1.41%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.2BMarket Cap
- 141.05%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$47.52+$0.66 (+1.41%)
Earnings Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 50.39% | ||
12-Month Momentum | 114.86% | ||
3-Month Risk Adjusted Momentum | 268.73% | ||
12-Month Risk Adjusted Momentum | 180.46% |
True Yield
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.11% |
Financial Health Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |